А. V. Dulaev

Assessment of safety of additional transplantation of autologous bone marrow mononuclear cells in the combined treatment of coronary heart disease. Results from a randomized, blind, placebo-controlled trial (TAMIS)

V. Lukashenko, G. Khubulava, E. Babenko, 2019, Russian Journal of Transplantology and Artificial Organs.